{{Rsnum
|rsid=678653
|Gene=CCND1
|Chromosome=11
|position=69651969
|Orientation=plus
|GMAF=0.4284
|Gene_s=CCND1,LOC100996515
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 14.3 | 39.7 | 46.0
| HCB | 0.0 | 18.2 | 81.8
| JPT | 2.3 | 27.3 | 70.5
| YRI | 66.1 | 33.9 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 18.2 | 81.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21268129
|Title=Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley-A high risk area
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=19124506
|Title=Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19372140
|Title=EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.
|OA=1
}}

{{PMID Auto
|PMID=21273603
|Title=Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan.
}}

{{PMID Auto
|PMID=21965784
|Title=Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
}}

{{PMID Auto
|PMID=22399638
|Title=Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
}}

{{PMID Auto
|PMID=23354566
|Title=Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}